Abstract 5145: Targeting TREX1 induces innate immune response in chemoresistant small cell lung cancer
Takahiko Murayama(Kanazawa University), Israel Cañadas(Fox Chase Cancer Center), Hideo Watanabe(St. Catherine University), Navin R. Mahadevan(Brigham and Women's Hospital), Xueying Ma(Fox Chase Cancer Center), David A. Barbie(Dana-Farber Cancer Institute), Tetsuo Tani(Keio University)
Cited by 2
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701
<i>Fusobacterium nucleatum</i>and T Cells in Colorectal Carcinoma
|JAMA Oncology|2015|660